Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1968
https://www.valueinhealthjournal.com/article/S1098-3015(15)04044-9/fulltext
Title :
Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04044-9&doi=10.1016/j.jval.2015.09.1968
First page :
A586
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1395